Van den Broek Hans Thijs, De Jong Leon, Doevendans Pieter A, Chamuleau Steven A J, Van Slochteren Frebus J, Van Es René
Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht.
Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht; MIRA Institute, University Twente.
J Vis Exp. 2017 Apr 12(122):54974. doi: 10.3791/54974.
Cardiac regenerative therapies aim to protect and repair the injured heart in patients with ischemic heart disease. By injecting stem cells or other biologicals that enhance angio- or vasculogenesis into the infarct border zone (IBZ), tissue perfusion is improved, and the myocardium can be protected from further damage. For maximum therapeutic effect, it is hypothesized that the regenerative substance is best delivered to the IBZ. This requires accurate injections and has led to the development of new injection techniques. To validate these new techniques, we have designed a validation protocol based on myocardial tissue analysis. This protocol includes whole-heart myocardial tissue processing that enables detailed two-dimensional (2D) and three-dimensional (3D) analysis of the cardiac anatomy and intramyocardial injections. In a pig, myocardial infarction was created by a 90-min occlusion of the left anterior descending coronary artery. Four weeks later, a mixture of a hydrogel with superparamagnetic iron oxide particles (SPIOs) and fluorescent beads was injected in the IBZ using a minimally-invasive endocardial approach. 1 h after the injection procedure, the pig was euthanized, and the heart was excised and embedded in agarose (agar). After the solidification of the agar, magnetic resonance imaging (MRI), slicing of the heart, and fluorescence imaging were performed. After image post-processing, 3D analysis was performed to assess the IBZ targeting accuracy. This protocol provides a structured and reproducible method for the assessment of the targeting accuracy of intramyocardial injections into the IBZ. The protocol can be easily used when the processing of scar tissue and/or validation of the injection accuracy of the whole heart is desired.
心脏再生疗法旨在保护和修复缺血性心脏病患者受损的心脏。通过将干细胞或其他促进血管生成的生物制剂注射到梗死边缘区(IBZ),可改善组织灌注,并保护心肌免受进一步损伤。为了达到最大治疗效果,据推测,再生物质最好输送到梗死边缘区。这需要精确注射,从而推动了新注射技术的发展。为了验证这些新技术,我们设计了一种基于心肌组织分析的验证方案。该方案包括全心肌组织处理,能够对心脏解剖结构和心肌内注射进行详细的二维(2D)和三维(3D)分析。在猪身上,通过闭塞左前降支冠状动脉90分钟造成心肌梗死。四周后,采用微创心内膜方法将含有超顺磁性氧化铁颗粒(SPIOs)和荧光珠的水凝胶混合物注射到梗死边缘区。注射操作1小时后,对猪实施安乐死,取出心脏并嵌入琼脂糖(琼脂)中。琼脂凝固后,进行磁共振成像(MRI)、心脏切片和荧光成像。图像后处理后,进行三维分析以评估梗死边缘区靶向准确性。该方案为评估心肌内注射到梗死边缘区的靶向准确性提供了一种结构化且可重复的方法。当需要处理瘢痕组织和/或验证全心脏注射准确性时,该方案可轻松使用。